TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07570264: A Prospective, Multicenter, Randomized, Evaluator-Blinded, Confirmatory Study to Evaluate the Efficacy and Safety of LEXURE for Improving Language Function in Patients With Post-Stroke Aphasia

Sponsor: Nunaps Inc · Phase: PHASE2 · Area: CNS_NEUROLOGY · Target Enrollment: 116 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$8,924,000

Rescue Site Savings

+$5,897,600

Unlock Full NCT07570264 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07570264 Rescue Dossier →